Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−3.99 USD
−81.58 M USD
20.13 M USD
7.19 M
About HOOKIPA Pharma Inc.
Sector
Industry
CEO
Malte Peters
Website
Headquarters
New York
Founded
2011
FIGI
BBG00NGMNKR4
HOOKIPA Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in developing pharmaceutical products to prevent and cure infectious diseases and cancer. The firm also focuses on immunotherapeutics based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. The company was founded by Rolf M. Zinkernagel, Andreas Bergthaler, Lukas Flatz, and Daniel D. Pinschewer in 2011 and is headquartered in New York, NY.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of HOOK is 2.72 USD — it has decreased by −2.51% in the past 24 hours. Watch HOOKIPA Pharma Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange HOOKIPA Pharma Inc. stocks are traded under the ticker HOOK.
HOOK stock has fallen by −24.86% compared to the previous week, the month change is a −34.62% fall, over the last year HOOKIPA Pharma Inc. has showed a −47.59% decrease.
We've gathered analysts' opinions on HOOKIPA Pharma Inc. future price: according to them, HOOK price has a max estimate of 50.00 USD and a min estimate of 7.00 USD. Watch HOOK chart and read a more detailed HOOKIPA Pharma Inc. stock forecast: see what analysts think of HOOKIPA Pharma Inc. and suggest that you do with its stocks.
HOOK reached its all-time high on May 18, 2021 with the price of 200.00 USD, and its all-time low was 2.85 USD and was reached on Nov 15, 2024. View more price dynamics on HOOK chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
HOOK stock is 7.25% volatile and has beta coefficient of 1.78. Track HOOKIPA Pharma Inc. stock price on the chart and check out the list of the most volatile stocks — is HOOKIPA Pharma Inc. there?
Today HOOKIPA Pharma Inc. has the market capitalization of 32.79 M, it has decreased by −18.42% over the last week.
Yes, you can track HOOKIPA Pharma Inc. financials in yearly and quarterly reports right on TradingView.
HOOKIPA Pharma Inc. is going to release the next earnings report on Mar 20, 2025. Keep track of upcoming events with our Earnings Calendar.
HOOK earnings for the last quarter are −1.10 USD per share, whereas the estimation was −1.28 USD resulting in a 14.06% surprise. The estimated earnings for the next quarter are −0.93 USD per share. See more details about HOOKIPA Pharma Inc. earnings.
HOOKIPA Pharma Inc. revenue for the last quarter amounts to 4.70 M USD, despite the estimated figure of 6.25 M USD. In the next quarter, revenue is expected to reach 6.25 M USD.
HOOK net income for the last quarter is −13.84 M USD, while the quarter before that showed −19.09 M USD of net income which accounts for 27.52% change. Track more HOOKIPA Pharma Inc. financial stats to get the full picture.
No, HOOK doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 151.00 employees. See our rating of the largest employees — is HOOKIPA Pharma Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HOOKIPA Pharma Inc. EBITDA is −42.42 M USD, and current EBITDA margin is −404.27%. See more stats in HOOKIPA Pharma Inc. financial statements.
Like other stocks, HOOK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HOOKIPA Pharma Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HOOKIPA Pharma Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HOOKIPA Pharma Inc. stock shows the sell signal. See more of HOOKIPA Pharma Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.